INDIANAPOLIS, July 12, 2019 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) announced the upcoming presentation of data highlighting inconsistent and sub-optimal treatment patterns that people living with migraine experience across the U.S. healthcare landscape, specifically related to where they receive care.1 These data are from the OVERCOME (O

BOSTON, July 12, 2019 /PRNewswire/ -- Quincy Miller, vice chair and president of Eastern Bank, has been elected to the board of directors of Blue Cross Blue Shield of Massachusetts.

STOCKHOLM, July 12, 2019 /PRNewswire/ -- During 14–17 July, RaySearch will exhibit its latest advances at the 61st AAPM Annual Meeting in San Antonio, US. The company will demonstrate RayCare® 3A*, the latest release of the groundbreaking oncology information system, and RayStation® 9A*, the new release of the innovative

WINSTON-SALEM, N.C., July 12, 2019 /PRNewswire/ -- Hundreds of high school students from around the world – including Rwanda, the United Arab Emirates, Australia, Korea, Italy, Bolivia and

CAMBRIDGE, Mass., July 12, 2019 /PRNewswire/ -- EIP Pharma, Inc., a CNS-focused therapeutics company, today announced the initiation of a new Phase 2 proof-of-concept study evaluating neflamapimod as a treatment for the cognitive dysfunction associated with dementia with Lewy bodies (DLB). The primary objective of the study is to determine whether neflamapimod, a br

INDIANAPOLIS, July 12, 2019 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) today announced the presentation of post-hoc analyses showing improvements in daily functioning and reductions in disability in patients with chronic and episodic migraine treated with Emgality® (galcanezumab-gnlm) compared to placebo.1 The analyses are based

COLUMBUS, Ga., July 12, 2019 /PRNewswire/ -- Aflac Incorporated (NYSE: AFL) announced today that it has entered into a definitive agreement to acquire Florida-based Argus Holdings, LLC and its subsidiary Argus Dental & Vision, Inc. (Argus), a premier benefits organization and national network dental and vision company. "We

STOCKHOLM, July 12, 2019 /PRNewswire/ -- Cyxone (publ.) a Swedish biotech in autoimmune diseases, today announced that the first healthy male volunteer has received the initial dose in its first-in-human, clinical phase I, trial with drug candidate T20K, in development for the treatment of multiple sclerosis (MS). The clinical phase I study is estimated to be conclude

VAUGHAN, ON, July 11, 2019 /PRNewswire/ - CannTrust Holdings Inc. ("CannTrust" or the "Company", TSX: TRST, NYSE: CTST) has announced it has implemented a voluntary hold on sale and shipment of all cannabis products as a precaution while Health Canada visits and reviews its Vaughan, Ontario manufacturing facility.

SANTA CLARA, Calif., July 11, 2019 /PRNewswire/ -- eHealth, Inc. (NASDAQ: EHTH), a leading private online health insurance exchange, announced today that the company plans to release second quarter 2019 financial results on July 25, 2019.Chief Executive Officer Scott Flanders and Chief Financial Officer Dere